By examining the association between risk scores and clinical features in both TCGA and CGGA cohorts, we found that the risk score was positively correlated with the grade of glioma (Figures 8C,F) and that it was significantly lower in the 1p/19q co-deletion and IDH mutation samples (Figures 8B,D,E,G). Here, IDH1 is linked to central nervous system cancer.